EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.
about
Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesisNon-SH2/PDZ reverse signaling by ephrinsTargeting the Eph System with Peptides and Peptide ConjugatesMicrovascular repair: post-angiogenesis vascular dynamicsp75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemiaPEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinityAttenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy.Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding.A pivotal role of the vascular endothelial growth factor signaling pathway in the formation of venous hypertension-induced dural arteriovenous fistulas.Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.Eph receptors and ephrins in cancer: bidirectional signalling and beyond.Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.Vessel arterial-venous plasticity in adult neovascularizationPeritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinomaHypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth.EphB4 as a therapeutic target in mesotheliomaEphB/ephrinB signaling in cell adhesion and migration.Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligandsPivotal role of pericytes in kidney fibrosis.EphrinB2 controls vessel pruning through STAT1-JNK3 signalling.Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.Semaphorin 6A regulates angiogenesis by modulating VEGF signalingA20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.Pericytes on the tumor vasculature: jekyll or hyde?EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injuryCellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta.Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.Myofibroblasts in Fibrotic Kidneys.Axon guidance molecules in vascular patterning.Targeting Eph receptors with peptides and small molecules: progress and challenges.Eph-dependent cell-cell adhesion and segregation in development and cancer.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Therapeutic targeting of EPH receptors and their ligands.The role of pericyte detachment in vascular rarefaction.Pericyte-expressed Tie2 controls angiogenesis and vessel maturation.Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.
P2860
Q21328694-1F0961BA-FFEA-4A8E-8D76-108FBFE9BCE3Q24629619-8C26AFD4-4C8B-454D-99D6-7D206CD4E713Q26799461-42A3E13A-80B2-4D50-9182-D326C7130BCBQ27004093-8C1F894E-C95F-40EB-9FAC-E6A94E2FBD2EQ28117855-1DEE5BA3-1EB1-4699-A698-C997A89367A2Q28741459-F4BF4171-3789-4A1B-8A0F-6EDDE0188E7BQ30414333-7894EB28-A7BD-41E9-9486-9D19603E72FBQ30493939-5E1F3925-083F-4B68-A7D8-7872E79DE1ADQ33608748-1D67C9A7-00CF-45A7-BE44-D6FCAD3CC70BQ33667093-8BE07006-82CF-49A8-8205-653DA4F4412CQ34021365-5842BA8A-92CF-49FC-86C6-DFC6DCCD47CBQ34026097-0B32DAE4-E8A0-43BE-B91C-F26860580DC0Q34031959-85F2AEBF-D1E5-426D-B002-A0F32BFF6CFBQ34075597-A7695219-437B-4776-8369-8D17BCA82FC7Q34087706-99BED310-0F18-48BC-A056-C190A9F48C74Q34364217-701C40AA-93D6-4603-A615-878B3E3681A7Q34566091-18EB70D9-613A-47B1-B33D-2485AB766EF5Q34747922-3BBA9A25-CBB3-465F-8191-74EC0B152A05Q35039009-A0B9331E-E414-4814-984A-BE32EED83065Q35069345-26FB64E9-5A61-49A9-AC44-BC038F448C13Q35072117-95231A74-0845-4C8B-9E51-80614928B94AQ35227778-AE3EEC53-5027-4DBB-9B0E-C7EAEED85341Q35783568-ADB6D3F9-3306-4733-B111-D0042C1E27AFQ36395624-82A95F66-22C7-4193-90FC-1AAA87D3EF9DQ36673788-604B203A-2E58-405A-B1EF-4772EE5B5E6AQ36695062-4107045B-43A7-4ECF-AA51-12ACD80E65DAQ36719255-FF92D897-DC2F-48DF-8355-65302F9553A5Q36763871-F58B2FF3-7138-430A-8FBE-151405A9B05CQ36765650-5C928480-2DDF-430F-B5A5-5EA21A0804E8Q36959852-FAA3B51C-451C-41F3-84B2-37FB2FF1B8E6Q37098831-3E823169-A08A-4385-93C2-2DCF8C362E45Q37262528-D6BAD628-76D6-4459-BC68-4B3EC108AB10Q37746510-CF3B7005-7746-41D5-85AC-931C09D034B9Q37951723-0D9F3F5B-51C8-46BB-B3F0-DE94399327CBQ37971902-9C5EB3CF-09A4-43B7-AFC7-C7A2C4FFFC18Q38006838-3C14FB72-0729-41FE-9D30-1C8E789F4C10Q38174793-52593504-3650-4A8D-A597-4C326E3101DCQ38246646-9B2A4EB8-3645-4640-80B6-DCF58E85C1CEQ38673791-5D37A294-B496-4DBE-9FC6-0CA01CACA93CQ38832513-C09ED11E-7D11-409A-B1BF-3752018BC0EB
P2860
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EphrinB reverse signaling cont ...... mbly into vascular structures.
@en
EphrinB reverse signaling cont ...... mbly into vascular structures.
@nl
type
label
EphrinB reverse signaling cont ...... mbly into vascular structures.
@en
EphrinB reverse signaling cont ...... mbly into vascular structures.
@nl
prefLabel
EphrinB reverse signaling cont ...... mbly into vascular structures.
@en
EphrinB reverse signaling cont ...... mbly into vascular structures.
@nl
P2093
P2860
P1433
P1476
EphrinB reverse signaling cont ...... embly into vascular structures
@en
P2093
Dragan Maric
Giovanna Tosato
Matina Economopoulou
Ombretta Salvucci
Shuhei Sakakibara
P2860
P304
P356
10.1182/BLOOD-2008-12-192294
P407
P577
2009-05-01T00:00:00Z